progestin primed ovarian stimulation protocol in the polycystic ovarian syndrome

progestin primed ovarian stimulation protocol in patients with the polycystic ovarian syndrome in assisted reproductive technology cycles

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110509006420N18

Enrollment

100

Registered

2018-08-20

Start date

2018-05-22

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility, unspecified. Female infertility, unspecified

Interventions

Intervention 1: Intervention group: since the second day of the cycle all patients Will receive 150 unit of cinal f(cinagen-Iran) Subcutaneously and 20 mg dydrogesterone (Duphaston) orally. when domin

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: infertile PCOS patients which are candidate for ART

Exclusion criteria

Exclusion criteria: women older than 40 years old History of endocrine disorder Severe endometriosis Azoospermia

Design outcomes

Primary

Measure	Time frame
Chemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: Serum BhCG.;Clinical pregnancy. Timepoint: Two weeks after positive BhCG. Method of measurement: sonography.	—

Secondary

Measure	Time frame
Miscarriage rate. Timepoint: Loss of pregnancy before 20 gestational week. Method of measurement: Absence of fetal heart activity in ultra sound sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Eftekhar

Yazd University of Medical Sciences

eftekharmaryam@yahoo.com+98 35 3824 7085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026